Sponsored by coronavirus
FAIR Health analysts now estimate, based on typical charges for flu and pneumonia care, that hospitals will probably charge an average of about $73,300 per patient for patients with COVID-19 who need inpatient care for pneumonia or other COVID-19 complications. Medicaid and Medicare may pay the hospitals only a small fraction of what the hospitals bill, but commercial insurers could end up paying more than half of the billed charges, according to the FAIR Health analysts. One offset may be that, for their own protection, physicians hope to treat most patients with mild SARS-CoV-2 infections through telehealth visits. FAIR Health analysts did not give a per-patient estimate of telehealth costs, but they found that commercial insurers typically pay $100 or less per telehealth visit for procedural codes related to colds, flu and other respiratory infections.
The FAIR Health analysts calculated separate hospitalization cost estimates based on whether the percentage of all Americans who get COVID-19 in 2020 is 20%, 40% or 60%, and whether the perentage who need inpatient hospital care is 15% of the patients who seek care or 20% of the patients who seek care. The Mildest Scenario (20% infected; 15% of those seeking care need hospital care)
CMS officials themselves have emphasized that COVID-19 could make a mockery of their 2020 health expenditures projections. "The latest projections begin after the latest historical year (2018) and go through 2028," officials state on the website presenting the data. "These projections do not take into account the impacts of COVID-19 because of the timing of the report and the highly uncertain nature of the pandemic." — Read America Will Dramatically Change the Way It Provides Health Care by 2030, on ThinkAdvisor. — Connect with ThinkAdvisor Life/Health on Facebook, LinkedIn and Twitter.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
Sponsored by Manulife John Hancock Investments
Exploring Private Credit's Journey to a Trillion-Dollar Asset Class
Sponsored by Manulife John Hancock Investments
What's missing from today's large-cap allocations? Value stocks
Sponsored by Manulife John Hancock Investments
Can Rolling Returns Offer a Better View of Investment Success?
Sponsored by Manulife John Hancock Investments
As Reinvestment Risk Emerges, How Should Investors Navigate Market Uncertainty?